Olmesartan Medoxomil
Brand name: Olmesartan Medoxomil
Rank #322 of 500 drugs by total cost
$33.8M
Total Cost
1,102,412
Total Claims
$33.8M
Total Cost
30,637
Prescribers
$31
Cost per Claim
203,682
Beneficiaries
2,725,124
30-Day Fills
$1,104
Avg Cost/Provider
36
Avg Claims/Provider
About Olmesartan Medoxomil
Olmesartan Medoxomil (sold as Olmesartan Medoxomil) was prescribed 1,102,412 times by 30,637 Medicare Part D providers in 2023, costing the program $33.8M. At $31 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 319 | Clonazepam (Clonazepam) | $34.4M | 3,685,968 |
| 320 | Tolvaptan (Jynarque) | $34.4M | 2,760 |
| 321 | Dalfampridine (Dalfampridine Er) | $34.1M | 40,425 |
| 322 | Olmesartan Medoxomil (Olmesartan Medoxomil) | $33.8M | 1,102,412 |
| 323 | Niraparib Tosylate (Zejula) | $33.7M | 2,206 |
| 324 | Tapentadol Hcl (Nucynta) | $33.6M | 29,886 |
| 325 | Dorzolamide Hcl/Timolol Maleat (Dorzolamide-Timolol) | $33.5M | 1,096,480 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology